Ipecac OTC Status Withdrawal Advised By NDAC Majority
This article was originally published in The Tan Sheet
Executive Summary
Ipecac syrup should not retain its OTC status as a treatment for accidental poisonings, a majority of the FDA Nonprescription Drugs Advisory Committee agreed at a June 12 meeting in Bethesda, Md